These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9387135)

  • 1. Glomerular atherosclerosis.
    Moorhead JF; Brunton C; Varghese Z
    Miner Electrolyte Metab; 1997; 23(3-6):287-90. PubMed ID: 9387135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure.
    Hasselwander O; Young IS
    Med Hypotheses; 1997 Nov; 49(5):389-95. PubMed ID: 9421803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial foam cells and oxidized lipoprotein in human glomerular disease.
    Magil AB
    Mod Pathol; 1999 Jan; 12(1):33-40. PubMed ID: 9950160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and progressive kidney disease.
    Moorhead JF
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidative modification of low density lipoprotein and its relation to atherosclerosis.
    Aviram M
    Isr J Med Sci; 1995 Apr; 31(4):241-9. PubMed ID: 7721566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxidized lipoproteins and atherogenesis].
    Bellomo G; Maggi E; Palladini G; Seccia M; Perani G; Marchesi E; Finardi G
    Cardiologia; 1996 May; 41(5):417-25. PubMed ID: 8767630
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach.
    Cobbold CA; Sherratt JA; Maxwell SR
    Bull Math Biol; 2002 Jan; 64(1):65-95. PubMed ID: 11868338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of atherogenic lipoproteins in hemodialysis patients: do they tell us more about their pathology?
    Kronenberg F; Ikewaki K; Schaefer JR; König P; Dieplinger H
    Semin Dial; 2007; 20(6):554-60. PubMed ID: 17991204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.